AbbVie Inc (NYSE:ABBV) Position Lowered by ETRADE Capital Management LLC

AbbVie (NYSE:ABBV) last issued its quarterly earnings results on Friday, January 26th.

Cutter & Company Brokerage Inc decreased its stake in Murphy Usa Inc (MUSA) by 9.2% based on its latest 2017Q3 regulatory filing with the SEC. Guardian Capital Lp bought 2,917 shares as the company's stock rose 6.51% with the market.

Carnegie Capital Asset Management Llc, which manages about $792.00M and $854.73 million US Long portfolio, upped its stake in Boeing Co (NYSE:BA) by 3,648 shares to 52,859 shares, valued at $13.87 million in 2017Q3, according to the filing. Vanguard Group Inc. now owns 115,920,673 shares of the company's stock valued at $8,405,409,000 after acquiring an additional 3,706,941 shares in the last quarter. About 520,308 shares traded. Murphy USA Inc. (NYSE:MUSA) has risen 4.83% since February 20, 2017 and is uptrending. It has underperformed by 1.24% the S&P500. $589,512 worth of stock was sold by Michael Robert A. on Thursday, September 28. Narain Duraiswami sold 2,860 shares worth $343,200. Investors of record on Friday, April 13th will be issued a dividend of $0.96 per share. Its up 0.61, from 0.67 in 2017Q2. Duncker Streett & Incorporated invested in 63,869 shares or 1.72% of the stock. C Gru A S reported 143,271 shares. Company insiders own 0.23% of the company's stock. Middleton And Com Ma holds 140,371 shares. WealthTrust Axiom LLC raised its stake in shares of AbbVie by 0.3% in the second quarter. Uss Management Ltd stated it has 903,800 shares. Cornerstone has invested 0.12% in Bank of Hawaii Corporation (NYSE:BOH). Susquehanna Gru Ltd Liability Partnership owns 222,496 shares or 0.01% of their United States portfolio. Moreover, Nbt Savings Bank N A NY has 1.18% invested in AbbVie Inc. Mark Sheptoff Financial Planning Llc sold 7,900 shares as the company's stock declined 3.48% while stock markets rallied. The company had revenue of $7.74 billion during the quarter, compared to analysts' expectations of $7.53 billion. 2,248 are held by Jones Fincl Lllp. Thomas Story And Son Ltd Liability Co reported 44,708 shares stake. One research analyst has rated the stock with a sell rating, eight have issued a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company's stock. Murphy USA had 18 analyst reports since September 8, 2015 according to SRatingsIntel.

AbbVie declared that its Board of Directors has authorized a stock repurchase program on Thursday, February 15th that permits the company to repurchase $10.00 billion in shares. The firm has "Outperform" rating by Cowen & Co given on Wednesday, October 11. The firm has "Market Perform" rating by BMO Capital Markets given on Friday, June 10. The rating was maintained by Piper Jaffray with "Hold" on Monday, July 24. The firm has "Buy" rating given on Tuesday, December 5 by Leerink Swann. The rating was downgraded by JP Morgan on Wednesday, October 26 to "Neutral". The firm's revenue for the quarter was up 13.9% compared to the same quarter past year. (NYSE:ABBV). 141,637 were reported by Fred Alger Management.

Since September 11, 2017, it had 0 buys, and 5 selling transactions for $25.59 million activity. The shares were sold at an average price of $98.45, for a total transaction of $8,569,088.00. The insider SALEKI-GERHARDT AZITA sold 8,300 shares worth $705,655.

Is Ed Sheeran Secretly Married?
The source said: "Ed is wearing a ring to show his commitment to being engaged to Cherry but he's not married yet". Cherry inspired Shape Of You and the Christmas number one flawless - so Ed fans have a lot to thank her for.

Investors sentiment decreased to 0.85 in 2017 Q3. It is negative, as 28 investors sold MUSA shares while 88 reduced holdings.

A number of other hedge funds have also recently made changes to their positions in ABBV. Moreover, David R Rahn Associate has 1.53% invested in AbbVie Inc. (NYSE:ABBV) has "Buy" rating given on Friday, September 15 by Jefferies. Inc. grew its holdings in shares of AbbVie by 1.6% during the 3rd quarter. Arrowstreet Capital Partnership has 0.68% invested in AbbVie Inc. Following the transaction, the chairman now directly owns 492,030 shares in the company, valued at $46,255,740.30. Sns Financial Group Inc Ltd Com holds 1.48% of its portfolio in AbbVie Inc. The firm also provides Hortonworks Sandbox, a personal, portable, and free to use Hadoop environment created to offer the easiest way to get started with HDP; Azure HDInsight, a data cloud service that provides clients flexible big data environments on the Azure cloud; and Hortonworks Data Cloud for Amazon Web Services, a big data cloud service for analyzing and processing data, and enabling businesses to achieve insights quickly and with flexibility. Thompson Siegel Walmsley Ltd Limited Liability Company has invested 0% in Westar Energy, Inc. Laurion Capital Mngmt LP invested 0.01% of its portfolio in Hanesbrands Inc. California Pub Employees Retirement has 0.02% invested in Bank of Hawaii Corporation (NYSE:BOH) for 132,026 shares. Monroe Bancorp Trust Mi invested 0.03% of its portfolio in AbbVie Inc. Alpine Woods Investors Limited has 0.14% invested in AbbVie Inc. Columbia Asset owns 30,420 shares. Retirement Systems Of Alabama accumulated 134,437 shares.

ILLEGAL ACTIVITY WARNING: "AbbVie Inc (ABBV) Position Boosted by Griffin Asset Management Inc." was first posted by Marea Informative and is the property of of Marea Informative. Therefore 48% are positive. Abbvie Inc had 78 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has "Overweight" rating by Morgan Stanley on Monday, November 2. SunTrust Banks lifted their price objective on AbbVie to $157.00 and gave the company an "average" rating in a research report on Monday, January 29th. The rating was maintained by Goldman Sachs on Friday, March 10 with "Buy". BMO Capital Markets set a $84.00 price target on AbbVie and gave the company a "hold" rating in a research report on Thursday, January 11th. The firm earned "Sell" rating on Wednesday, April 6 by Societe Generale. Trading volume for AbbVie Inc. was 8.58 Million in its previous trading session. AbbVie now has an average rating of "Buy" and an average target price of $118.44.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. (NYSE:ABBV) on Monday, October 30 with "Outperform" rating. It also increased its holding in Shire Plc (NASDAQ:SHPG) by 4.15 million shares in the quarter, for a total of 5.87M shares, and has risen its stake in Dun & Bradstreet Corp Del Ne (NYSE:DNB).

Related Articles